Literature DB >> 23187880

Diagnostic validity of CT gastrography versus gastroscopy for primary lesions in gastric cancer: evaluating the response to chemotherapy, a retrospective analysis.

Sho Takahashi1, Michiaki Hirayama, Ganji Kuroiwa, Yutaka Kawano, Kohichi Takada, Tsutomu Sato, Koji Miyanishi, Yasushi Sato, Rishu Takimoto, Masayoshi Kobune, Junji Kato.   

Abstract

BACKGROUND: This retrospective study was carried out to compare computed tomographic (CT) gastrography and conventional optical gastroscopy (GS) in order to evaluate the effectiveness of chemotherapy in primary gastric lesions.
METHODS: Patients with unresectable advanced and unresected early gastric cancer who had primary lesions and had received chemotherapy were enrolled. For primary lesions, CT gastrography and endoscopic assessment were done after chemotherapy, based on the Japanese Classification of Gastric Carcinoma (JCGC) criteria, 13th edition, and the Response Evaluation Criteria in Solid Tumors (RECIST). For metastatic solid lesions including lymph nodes, CT assessment was done based on the RECIST criteria.
RESULTS: Data from 23 patients were analyzed. With median follow-up of 9.4 months (range 2-23 months), 58 examinations were assessed by GS and CT gastrography. Setting optical endoscopic results as the gold standard, the accuracy of CT gastrography for primary gastric lesions was 77.6 % (45 of 58) (weighted κ = 0.72; P < 0.01) according to the JCGC 13th edition criteria and 90.0 % (52 of 58) (weighted κ = 0.75; P < 0.01) according to the RECIST. When all results were divided into two groups [the non-progressive disease (non-PD) group and PD group], accuracy was 93.1 % (52 of 58) (κ = 0.81; P < 0.01), sensitivity was 100 %, and specificity was 75.0 % (12 of 16). In addition, the predictability of PD was 100 % (12 of 12). The four cases of failure in specification were the following: a case of gastric remnant cancer, a case with insufficient distension of the stomach, a healed case with stenosis and scarring, and a case in which the wrong position had been selected for the examination. The average period until PD was 9.9 months (range 5-18 months), and the concordance period between GS and CT gastrography was 7.2 months in both non-PD and PD cases.
CONCLUSIONS: There was good concordance between the evaluations of GS and CT gastrography. CT gastrography exhibited favorable results in accuracy as well as 100 % PD predictability, which implied the possibility of using CT gastrography as a substitute for endoscopic assessments at post-chemotherapy assessments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23187880     DOI: 10.1007/s10120-012-0217-7

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  6 in total

1.  CT evaluation of gastric lesions with three-dimensional display and interactive virtual endoscopy: comparison with conventional barium study and endoscopy.

Authors:  I Ogata; Y Komohara; Y Yamashita; K Mitsuzaki; M Takahashi; M Ogawa
Journal:  AJR Am J Roentgenol       Date:  1999-05       Impact factor: 3.959

2.  Measurement of observer agreement.

Authors:  Harold L Kundel; Marcia Polansky
Journal:  Radiology       Date:  2003-06-20       Impact factor: 11.105

3.  CT virtual endoscopy of the stomach: comparison study with gastric fiberscopy.

Authors:  K Inamoto; K Kouzai; T Ueeda; T Marukawa
Journal:  Abdom Imaging       Date:  2005 Jul-Aug

4.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

5.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

6.  Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer.

Authors:  A Kiyohashi; M Kurihara; S Yoshida; T Ohkubo; S Suga
Journal:  Jpn J Clin Oncol       Date:  1993-02       Impact factor: 3.019

  6 in total
  4 in total

1.  MicroRNA-145 as ideal biomarker for the diagnosis of various carcinomas.

Authors:  Yanmei Hou; Xiang Wang; Yan Chen; Shengqun Mu
Journal:  Tumour Biol       Date:  2014-12-05

2.  Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.

Authors:  Ran Wang; Hong Wen; Yongcheng Xu; Qiulan Chen; Yi Luo; Yiqin Lin; Yu Luo; Angao Xu
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

3.  Effect of the degree of gastric filling on the measured thickness of advanced gastric cancer by computed tomography.

Authors:  Li Yang; Yong Li; Tao Zhou; Gaofeng Shi; Jiangyang Pan; Jing Liu; Guangda Wang
Journal:  Oncol Lett       Date:  2018-06-05       Impact factor: 2.967

4.  Advanced gastric cancer: CT radiomics prediction and early detection of downstaging with neoadjuvant chemotherapy.

Authors:  Qinmei Xu; Zeyu Sun; Xiuli Li; Chen Ye; Changsheng Zhou; Longjiang Zhang; Guangming Lu
Journal:  Eur Radiol       Date:  2021-04-28       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.